Valuation: DiaSorin S.p.A.

Market Cap 3.9B 4.45B 3.68B 3.36B 6.28B 426B 6.33B 44.08B 17.07B 218B 16.69B 16.33B 700B P/E 2026 *
22.8x
P/E 2027 * 20.2x
Enterprise Value 4.61B 5.25B 4.35B 3.97B 7.42B 503B 7.48B 52.07B 20.17B 257B 19.71B 19.29B 826B EV / Sales 2026 *
3.73x
EV / Sales 2027 * 3.39x
Free-Float
37.17%
Yield 2026 *
1.65%
Yield 2027 * 1.73%
1 day+0.33%
1 week+2.85%
Current month+3.85%
1 month+4.15%
3 months+15.31%
6 months+33.06%
Current year+14.84%
1 week 75.26
Extreme 75.26
79.72
1 month 72.7
Extreme 72.7
79.72
Current year 52.34
Extreme 52.34
79.72
1 year 52.34
Extreme 52.34
80.38
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
204.4
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
3/24/26 Buy

Chief Executive Officer

9,211 0.0165%
1/28/26 Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%+2.85%+6.29%-7.10% 4.45B
+0.45%-1.19%+195.27%+587.02% 23.79B
+1.90%+11.89%+631.31%+109.77% 11.17B
+0.71%+8.52%-31.24%-13.65% 10.42B
-0.90%+6.67%+9.56% - 9.04B
+0.02%-0.81%+97.08%+52.81% 6.51B
-2.43%-2.47%-30.14%-26.61% 5.59B
-2.61%-0.71%+60.04%+64.83% 3.86B
-2.29%+4.60%-14.51%-26.19% 2.86B
-0.02%-3.28% - - 1.5B
Average -0.48%+2.61%+102.63%+92.61% 7.92B
Weighted average by Cap. +0.03%+3.19%+156.26%+224.15%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.17B 1.06B 1.99B 135B 2B 13.95B 5.4B 68.88B 5.28B 5.17B 221B 1.31B 1.49B 1.24B 1.13B 2.11B 143B 2.13B 14.81B 5.74B 73.12B 5.61B 5.49B 235B
Net income 183M 209M 173M 158M 295M 19.99B 297M 2.07B 801M 10.21B 783M 766M 32.82B 206M 234M 194M 177M 331M 22.46B 334M 2.32B 900M 11.47B 880M 861M 36.87B
Net Debt 707M 805M 667M 608M 1.14B 77.18B 1.15B 7.99B 3.09B 39.43B 3.02B 2.96B 127B 542M 618M 512M 466M 873M 59.19B 879M 6.12B 2.37B 30.24B 2.32B 2.27B 97.19B
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
26-09-25 €78.80 +0.33% 104,002
26-09-24 €78.54 +0.54% 261,652
26-09-23 €78.12 +2.55% 112,946
26-09-22 €76.18 -2.31% 238,004
26-09-21 €77.98 +1.77% 242,921
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
78.80EUR
Average target price
72.81EUR
Spread / Average Target
-7.61%

Quarterly revenue - Rate of surprise